La catena delle opzioni mostra i dati chiave delle opzioni azionarie di GOLDEN RAPTURE MNG CORP by GOLDEN RAPTURE MNG CORP. a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per GOLDEN RAPTURE MNG CORP by GOLDEN RAPTURE MNG CORP...

GOLDEN RAPTURE MNG CORP by GOLDEN RAPTURE MNG CORP. (OTC:GLDRF) Azioni, Catena delle Opzioni

GOLDEN RAPTURE MNG CORP by GOLDEN RAPTURE MNG CORP.

Roth Capital analyst Joe Reagor reiterates Silvercorp Metals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SVM#AMEX">SVM</a>) with a Buy and raises the price target from $6.25 to $6.75.

News

Price Target

Reiteration

Analyst Ratings

Roth Capital Reiterates Buy on Silvercorp Metals, Raises Price Target to $6.75

Roth Capital analyst Joe Reagor reiterates McEwen Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUX#NYSE">MUX</a>) with a Buy and raises the price target from $12 to $15.

Roth Capital Reiterates Buy on McEwen Mining, Raises Price Target to $15

Avadel Pharmaceuticals Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) is under fire from its shareholder ASL Strategic Value Fund, LP, which is pushing for a complete overhaul of the board following what it describes as a series of strategic failures tied to Lumryz, the company&#8217;s <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">once-nightly narcolepsy treatment</a>.
In a letter released Monday, ASL argued Avadel failed to capitalize on Lumryz&#8217;s market potential, costing the company hundreds of millions in revenue and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b46164920/asl-strategic-value-fund-issues-open-letter-to-avadel-shareholders" rel="noreferrer noopener">diminishing shareholder value</a>.
ASL, which holds approximately $15 million in Avadel stock, criticized the company&#8217;s slow patient conversion from Jazz Pharmaceutical Plc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) Xyrem to Lumryz, despite the latter having been deemed &#8220;clinically superior&#8221; by the FDA.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42891870/avadel-pharmaceuticals-misses-earnings-estimate-but-posts-150-increase-in-sales-from-its-narcolepsy-drug-lumryz" rel="noreferrer noopener">Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ</a>
Since Lumryz&#8217;s approval in 2021, only about 1,000 patients have made the switch, which ASL estimates represents a $600 million to $800 million shortfall.
The group called this delay in targeting Xyrem patients a &#8220;strategic blunder,&#8221; claiming it has shaved $5 to $7 per share from shareholder value.
The fund is urging shareholders to vote out the current board at the July 29 annual meeting. It is pressing Avadel to engage an investment bank to evaluate options for monetizing Lumryz.
This includes exploring partnerships or licensing deals, particularly given its recent Orphan Drug Designation for idiopathic hypersomnia (IH), a move that could generate an additional $500 million to $1 billion in annual revenue if Lumryz is approved for the rare sleep disorder.
Avadel defended its strategy, saying it is actively working with major shareholders and remains committed to unlocking Lumryz&#8217;s full value.
The company also highlighted a recent legal win in which a U.S. court affirmed the FDA&#8217;s conclusion that Lumryz&#8217;s once-nightly dosing is clinically superior to its competitors. However, ASL pointed to ongoing litigation with Jazz Pharmaceuticals, six lawsuits in total, as another area where the board has underdelivered.
With one case heading to trial within four months and over $1 billion at stake, ASL accuses leadership of failing to act urgently or communicate the opportunity to investors.
Beyond strategic concerns, ASL cited governance issues, including uncounted shareholder votes and a lack of transparency around executive pay.
Despite Avadel&#8217;s falling market capitalization, from $2.5 billion to $900 million over two years, CEO compensation was $7.4 million in 2024, raising further concerns over accountability.
On Friday, Avadel Pharmaceuticals said the U.S. Court of Appeals for the D.C. Circuit upheld a lower court&#8217;s decision siding with the U.S. Food and Drug Administration (FDA) in a case <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g46164897/avadel-pharmaceuticals-announces-unanimous-appeals-court-decision-upholding-fda-approval-of-lumryz" rel="noreferrer noopener">brought by Jazz Pharmaceuticals</a>.
Earlier in June, the FDA granted Orphan Drug Designation to Lumryz for <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g45789373/avadel-pharmaceuticals-receives-orphan-drug-designation-from-fda-for-lumryz-sodium-oxybate-for-ext" rel="noreferrer noopener">Idiopathic Hypersomnia</a>.
Price Action: AVDL stock is trading lower by 0.40% to $8.83 at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46199715/warner-bros-discovery-wbd-stock-slides-on-major-stake-sale" target="_blank" rel="noreferrer noopener">Warner Bros. Discovery (WBD) Stock Slides On Major Stake Sale</a></li>
</ul>
Photo by Gorodenkoff via Shutterstock

Biotech

Health Care

General

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

JAZZ

Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz

LIXT

Lixte Biotechnology Granted U.S. Patent #12343342: Methods For Treating Soft Tissue Sarcoma

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) price may continue to stay within its <a href="https://www.benzinga.com/money/bitcoin-price-prediction">current trading range</a> despite rising institutional interest and significant ETF inflows, according to Michael Bucella, managing partner at Neoclassic Capital.
In an <a href="https://www.youtube.com/watch?v=j09LmitdAL4">interview</a> with CNBC on Tuesday, Bucella explained that although demand for Bitcoin is strong, structural factors are preventing further price movement.
&#8220;ETF inflows have been enormous, I think $4 billion in June alone,&#8221; Bucella said, highlighting the surge of institutional capital entering Bitcoin through regulated products. 
However, he pointed out that this demand is not directly translating into higher prices.
Bucella said that some investors are rotating out of Bitcoin spot positions and into crypto-related equities like Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), Circle (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>), and Bitcoin treasury companies, shifting how they gain exposure to the asset class. 
&#8220;There&#8217;s people replacing Bitcoin spot risk with Circle or Coinbase or treasury companies,&#8221; he noted.
One of the key supply-side pressures, according to Bucella, comes from Bitcoin miners who are now operating on increasingly narrow margins. 
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46174956/solana-etf-approval-imminent-as-odds-skyrocket-to-97">Solana ETF Approval Imminent As Odds Skyrocket To 97%</a>
&#8220;If you don&#8217;t have highly credible, high top assets with great operating teams to pivot to at least attempt to get an AI contract or a hyperscaler contract, you have to sort of run these sometimes loss operating models,&#8221; Bucella said. 
He added that this is leading some miners to sell Bitcoin to sustain their operations.
Despite Bitcoin&#8217;s year-to-date gains of approximately 15%, Bucella noted that the asset's performance has not aligned with the strength seen in broader equity markets. 
&#8220;It is a bit surprising to have seen the price of Bitcoin stay stuck in this sort of range,&#8221; he said.
Why It Matters: Bucella also commented on Bitcoin's behavior during recent geopolitical tensions.
During the Israel-Iran conflict escalation, Bitcoin sold off, showing that it continues to behave like a risk asset rather than acting as a defensive hedge. 
&#8220;If it&#8217;s not going to [act like digital gold], to me, its most valuable kind of selling point is when it acts like digital gold,&#8221; Bucella said.
Looking at the broader market, Bucella observed that demand remains strong for Bitcoin treasury companies, but smaller firms may need to develop more diversified models beyond simply holding Bitcoin to remain attractive to investors.
He also commented on Circle's valuation surge following its IPO, suggesting that the company's potential to reshape payment systems, rather than simply its stablecoin issuance, may be what investors are focusing on. 
&#8220;What Circle represents is potentially destabilizing the traditional payments and traditional capital markets rails,&#8221; Bucella said.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46173137/the-investment-rule-ric-edelman-just-threw-out-and-what-he-replaced-it-with">The Investment Rule Ric Edelman Just Threw Out—And What He Replaced It With</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$USDC

COIN

Why Bitcoin Is Trapped In A Range Despite Record ETF, Treasury Company Flows

WIIM

WETO

WETO stock has given up its prior gain. Webus International shares were trading higher after the company announced it secured up to $100 million in equity financing with Ripple Strategy Holdings.

Asset Sales

Sturm Ruger Announces Asset Purchase Of Anderson Manufacturing: Terms Not Disclosed

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fthearenagroup.net%2F&amp;esheet=54284886&amp;newsitemid=20250701744150&amp;lan=en-US&amp;anchor=The+Arena+Group+Holdings%2C+Inc.&amp;index=1&amp;md5=5948f435552dffedd66c9e29d573ae2c">The Arena Group Holdings, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AREN#NYSE">AREN</a>) ("Arena"), a technology platform and media company home to hundreds of media brands, including TheStreet, Parade, Men's Journal, Athlon Sports, Surfer, Powder and more, today announced it has been added as a member of the Russell 2000&#xAE; Index, effective as of June 30, 2025 as part of the 2025 Russell U.S. Indexes reconstitution.
Membership in the Russell 2000&#xAE; Index reflects inclusion in the broader Russell 3000&#xAE; Index, which captures the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization. Companies are also included in the appropriate growth and value style indexes as well. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

AREN

Arena Group Holdings Added To Russell 2000 Index, Signaling Broader Russell 3000 Index Inclusion

Roth Capital analyst Joe Reagor maintains MAG Silver (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MAG#AMEX">MAG</a>) with a Neutral and raises the price target from $18 to $21.

Roth Capital Maintains Neutral on MAG Silver, Raises Price Target to $21

If you've ever wished there was a simple way to enjoy pure, mineral-rich water and freshly brewed coffee without the hassle of refills, plumbing hookups, or endless plastic waste, you're down to your final chance to make it happen. Kara Pod — the world's first self-refilling coffee machine that generates clean drinking water straight from the air — is almost at the finish line of its Kickstarter campaign. Early supporters<a href="https://www.kickstarter.com/projects/karawater/karapod?ref=48p363"> have less than 25 hours left to lock in exclusive savings that won't be offered again</a>, with discounts reaching up to $340 off the expected retail price. Whether you live in a small apartment, an off-grid cabin, or a busy family home, Kara Pod offers a way to drink better without compromise, and time to secure yours is almost up.
<h2 class="wp-block-heading">What Makes Kara Pod Different?</h2>
At first glance, <a href="https://www.kickstarter.com/projects/karawater/karapod?ref=48p363">Kara Pod</a> looks like a sleek countertop coffee machine. But inside, it's doing something remarkable. Instead of requiring a plumbing connection or water deliveries, Kara Pod draws moisture directly from the surrounding air. Using advanced filtration and purification, it transforms that humidity into fresh, alkaline water you can drink immediately or use to brew coffee. Every drop passes through a multi-stage process that includes dual UV sterilization, a carbon filter, and final mineralization, so you end up with clean, great-tasting water enhanced with calcium, magnesium, and sodium. The internal 3.2-liter tank holds enough for about seven bottles of water or up to eighteen cups of coffee each day, and because everything is automated, you never have to refill a jug or connect a hose — just plug it in and let it get to work.
<h2 class="wp-block-heading">Coffee and Hydration in One Appliance</h2>
Beyond its water-generating abilities, Kara Pod is also a full-featured coffee maker designed to deliver a barista-quality experience. It's compatible with both Kara's own compostable coffee pods and Nespresso Original Pods, so you can choose your preferred blend or roast. Unlike many all-in-one machines, Kara Pod has separate dispensing nozzles — one dedicated to water, the other to coffee — so there's no crossover of flavors or residues. Through the touchscreen, you can customize cup size, adjust coffee strength, and save your favorite settings. That means you can pour a glass of fresh mineral water and then immediately brew an espresso without swapping tanks or cleaning components in between. It's an unusually thoughtful design for anyone who wants both hydration and high-quality coffee without cluttering the kitchen.
<h2 class="wp-block-heading">No Refills, No Plumbing, No Plastic Waste</h2>
A big reason so many people have backed Kara Pod is how effortless it is to operate. There's no need for bottled water, no expensive delivery contracts, and no refilling a reservoir every day. Kara Pod simply creates water as you need it, drawing from the air in your kitchen or workspace. Because it runs on standard power outlets — either 110V or 220V — it works almost anywhere. This design doesn't just save you time; it also significantly reduces your environmental footprint. You won't be throwing away single-use plastic bottles, hauling delivery jugs, or creating unnecessary waste. Even the coffee pods are compostable.
<h2 class="wp-block-heading">Technical Details at a Glance</h2>
While Kara Pod is compact, it's packed with capability. The machine measures roughly 15 inches by 9 inches by 14 inches — comparable in size to a Keurig K-Select — and weighs about 13 pounds. It has a storage capacity of 3.2 liters, enough for daily use by singles, couples, or small families. The power consumption is 270 watts, and the voltage range is fully compatible with both US and international outlets. All controls are handled through an intuitive touchscreen that walks you through setup, customization, and maintenance reminders.
<h2 class="wp-block-heading">Who Is Kara Pod Designed For?</h2>
Kara Pod is an easy fit for a wide range of people and spaces. If you live in an apartment where tap water is unreliable or tastes unpleasant, Kara Pod gives you a consistent source of mineral-rich water without plumbing. For off-grid living, RV trips, or cabins where running water isn't practical, it offers a self-sufficient hydration solution. Families looking to cut back on plastic waste will appreciate how it replaces bottled water entirely, while small offices and workspaces can use it to provide healthier, hassle-free drinks throughout the day. Essentially, anyone who wants clean water and quality coffee, anywhere, will find Kara Pod surprisingly versatile.
<h2 class="wp-block-heading">Kickstarter Pricing and Rewards</h2>
During this final stretch of the campaign, backers can still claim significant savings. A <a href="https://www.kickstarter.com/projects/karawater/karapod?ref=48p363">single Kara Pod is available starting from $459</a>, which represents up to $340 off the estimated retail price. There are also bundled options — like a single unit plus extra filter sets for longer-term use, starting around $477, or multi-unit packages ideal for gifting or outfitting multiple rooms. Shipping costs will be calculated after the campaign wraps up, and you can view estimated rates directly on the Kickstarter page. Given how quickly the campaign is closing, many reward tiers are almost sold out.
<h2 class="wp-block-heading">Why Back Kara Pod Before Time Runs Out?</h2>
Backing Kara Pod now isn't just about getting the best price. Early backers play a pivotal role in making this new category of appliance widely available. The project is structured as all-or-nothing — if it doesn't hit the funding goal by Wednesday, July 2, 2025, at 6:45 AM (Pacific), production won't proceed and your card won't be charged. Already, hundreds of backers have pledged support and shared feedback, with a lively comment section and transparent updates from the creators. If you've been considering it, this is the moment to act.
<h2 class="wp-block-heading">How to Reserve Your Kara Pod</h2>
There are only hours left to secure your Kara Pod and start transforming how you drink water and coffee every day. Backing is simple: just visit the Kickstarter page, choose your reward, and complete your pledge before the campaign closes. After that, these early-backer discounts will disappear, and you'll have to wait for retail availability at full price. Invest now with as little a $1, or <a href="https://www.kickstarter.com/projects/karawater/karapod?ref=48p363">invest $459 to get a Kara Pod</a> (at a discount of 43% off its retail price). No refills. No plumbing. No plastic. Just a better way to stay hydrated—and you have less than 25 hours to claim it.

Tech

Only 25 Hours Left: Back Kara Pod and Invest Early in the Future of Air-to-Water Tech

Roth Capital analyst Joe Reagor reiterates Coeur Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) with a Buy and raises the price target from $10 to $12.

Roth Capital Reiterates Buy on Coeur Mining, Raises Price Target to $12

Jumia Technologies AG &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NYSE">JMIA</a>) shares are trading higher Tuesday afternoon as the company becomes the subject of takeover interest from Axian Telecom, per a Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-07-01/e-commerce-firm-jumia-said-to-draw-takeover-interest-from-axian">report</a>.
What To Know: Axian Telecom recently raised $600 million in financing, according to sources who spoke with Bloomberg. These funds are intended to refinance existing debt and strategically position the company for a possible acquisition of Jumia. Deliberations are <a href="https://www.bloomberg.com/news/articles/2025-07-01/e-commerce-firm-jumia-said-to-draw-takeover-interest-from-axian">reportedly</a> ongoing and private, with no definitive agreement reached, per Bloomberg.
This potential merger follows Axian&#8217;s disclosure in May of an 8% stake in Jumia. Such an acquisition could create a powerful synergy, combining Axian&#8217;s telecommunications infrastructure with Jumia&#8217;s established e-commerce network. Representatives for both Jumia and Axian have declined to comment to Bloomberg on the speculation.
What Else: Jumia is a leading <a href="https://www.benzinga.com/topic/e-commerce">e-commerce</a> platform in Africa, often called the &#8220;Amazon of Africa.&#8221; It provides a marketplace for consumers to buy a wide range of products, a logistics service for delivery and a payment platform, JumiaPay.
News of a potential takeover by Axian Telecom would likely cause Jumia&#8217;s stock to rise for a key reason: acquisition premium. Typically, a company seeking to acquire another offers to buy its shares at a price higher than the current market value. 
The prospect of this higher payout makes the stock more attractive, driving up its price as investors anticipate the potential acquisition.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, JMIA shares are trading higher by 16.5% to $4.67. JMIA has a 52-week high of $15.04 and a 52-week low of $1.60.
Read Also: <a href="https://www.benzinga.com/pressreleases/25/06/ac46181754/jumia-opens-new-warehouse-in-egypt-to-boost-logistics-job-creation-and-digital-economy">Jumia Opens New Warehouse in Egypt to Boost Logistics, Job Creation, and Digital Economy</a>
<h2 class="wp-block-heading">How To Buy JMIA Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Jumia Technologies&#8217; case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

JMIA

Jumia (JMIA) Stock Surges On Axian Takeover Buzz: What Investors Need To Know

Roth Capital analyst Joe Reagor maintains Anglogold Ashanti (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>) with a Buy and raises the price target from $52 to $54.

Roth Capital Maintains Buy on Anglogold Ashanti, Raises Price Target to $54

Roth Capital analyst Joe Reagor downgrades Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) from Buy to Neutral and raises the price target from $2.75 to $3.5.

Downgrades

Roth Capital Downgrades Avino Silver & Gold Mines to Neutral, Raises Price Target to $3.5

Leader in vessel monitoring and control solutions joins Teledyne's Raymarine brand
Teledyne Technologies Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) ("Teledyne") announced today the acquisition of assets of Maretron, including the brand's Octoplex, MPower and MConnect product lines from Littelfuse, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFUS#NASDAQ">LFUS</a>). The purchase will allow Teledyne's Raymarine business to deliver deeper integration and automation for boat builders as a one-stop-shop, greatly expand product functionality for consumers, and create new and exciting business opportunities for Raymarine and its partners. Raymarine intends to maintain Maretron's trade name and product lines to ensure a seamless transition for existing Maretron customers.

LFUS

Teledyne Technologies Acquires Assets Of Maretron, Including Brand's Octoplex, MPower And MConnect Product Lines From Littelfuse; Terms Undisclosed

<h3>Gainers</h3>
<ul>
<li>Studio City Intl Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSC#NYSE">MSC</a>) shares moved upwards by 31.6% to $4.18 during Tuesday's regular session. The market value of their outstanding shares is at $611.4 million. </li>
<li>Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) shares rose 20.28% to $1.66. The company's market cap stands at $41.6 million. </li>
<li>Jumia Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JMIA#NYSE">JMIA</a>) stock increased by 16.04% to $4.67. The market value of their outstanding shares is at $492.3 million. </li>
<li>Sonder Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOND#NASDAQ">SOND</a>) stock rose 14.37% to $3.09. The company's market cap stands at $29.7 million. </li>
<li>Bloomin Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) stock rose 14.22% to $9.84. The market value of their outstanding shares is at $732.3 million. </li>
<li>Designer Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBI#NYSE">DBI</a>) stock rose 13.65% to $2.71. The market value of their outstanding shares is at $116.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) stock fell 29.1% to $0.16 during Tuesday's regular session. The company's market cap stands at $11.7 million. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares declined by 23.15% to $0.33. </li>
<li>Flanigan'S Enterprises (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BDL#AMEX">BDL</a>) shares declined by 16.48% to $29.0. The company's market cap stands at $64.5 million. </li>
<li>Dogness (Intl) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) shares fell 16.22% to $13.74. The company's market cap stands at $233.3 million. </li>
<li>Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) shares decreased by 15.34% to $0.25. The market value of their outstanding shares is at $12.4 million. </li>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) shares decreased by 12.85% to $1.22. The company's market cap stands at $1.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BLMN

DOGZ

LVLU

LXEH

MULN

SOND

TLYS

12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Neurogene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGNE#NASDAQ">NGNE</a>) shares increased by 32.3% to $19.77 during Tuesday's regular session. The market value of their outstanding shares is at $213.2 million. </li>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) stock increased by 32.16% to $0.4. The company's market cap stands at $4.7 million. </li>
<li>Lixte Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) shares moved upwards by 27.66% to $1.16. The market value of their outstanding shares is at $2.4 million. </li>
<li>Vivos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) shares increased by 25.47% to $3.96. The company's market cap stands at $18.6 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock increased by 18.32% to $1.55. The market value of their outstanding shares is at $4.2 million. </li>
<li>Mustang Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares moved upwards by 18.22% to $1.13. The company's market cap stands at $4.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) stock fell 57.3% to $1.63 during Tuesday's regular session. The company's market cap stands at $2.7 million. </li>
<li>Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) shares decreased by 46.0% to $0.47. The market value of their outstanding shares is at $13.7 million. </li>
<li>Cellectar Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) stock fell 31.23% to $4.89. The market value of their outstanding shares is at $12.8 million. </li>
<li>Artelo Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>) stock decreased by 28.33% to $9.51. The company's market cap stands at $7.2 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares decreased by 14.64% to $6.01. The market value of their outstanding shares is at $44.4 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Enhabit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHAB#NYSE">EHAB</a>) shares fell 14.16% to $8.28. The company's market cap stands at $488.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADIL

ARTL

CLRB

EHAB

GOVX

MBIO

NGNE

OGEN

SNGX

VVOS

XCUR

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) stock moved upwards by 230.9% to $10.16 during Tuesday's regular session. The company's market cap stands at $5.5 million. </li>
<li>Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) shares moved upwards by 19.76% to $5.09. The market value of their outstanding shares is at $710.4 million. </li>
<li>WF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) stock rose 18.14% to $3.19. The company's market cap stands at $18.6 million. </li>
<li>Shimmick (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHIM#NASDAQ">SHIM</a>) stock increased by 16.37% to $1.99. The market value of their outstanding shares is at $58.8 million. </li>
<li>FiscalNote Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) shares increased by 15.3% to $0.62. The company's market cap stands at $84.8 million. </li>
<li>BGSF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGSF#NYSE">BGSF</a>) shares moved upwards by 12.27% to $7.15. The company's market cap stands at $70.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) stock fell 39.4% to $0.07 during Tuesday's regular session. The market value of their outstanding shares is at $1.7 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) stock decreased by 26.96% to $0.24. The market value of their outstanding shares is at $46.9 million. </li>
<li>Capstone Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPS#NASDAQ">CAPS</a>) stock declined by 18.89% to $1.46. The company's market cap stands at $9.3 million. </li>
<li>Professional Diversity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) stock fell 17.16% to $2.8. The company's market cap stands at $7.0 million. </li>
<li>Arrive AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAI#NASDAQ">ARAI</a>) stock decreased by 11.69% to $10.31. The company's market cap stands at $385.3 million. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) stock fell 11.42% to $1.63. The company's market cap stands at $13.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARAI

BGLC

BGSF

CAPS

IPDN

NOTE

SCWO

SHIM

SHLS

12 Industrials Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares increased by 125.7% to $0.9 during Tuesday's regular session. The company's market cap stands at $62.0 million. </li>
<li>BitMine Immersion Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) stock increased by 89.67% to $64.3. The market value of their outstanding shares is at $205.5 million. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) shares moved upwards by 83.1% to $0.34. The market value of their outstanding shares is at $11.8 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) stock moved upwards by 74.6% to $10.04. The market value of their outstanding shares is at $9.9 million. </li>
<li>Saiheat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIH#NASDAQ">SAIH</a>) shares moved upwards by 20.02% to $8.57. The market value of their outstanding shares is at $12.1 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNHP#NASDAQ">SLNHP</a>) shares rose 16.27% to $3.0. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Youxin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YAAS#NASDAQ">YAAS</a>) stock declined by 86.8% to $0.55 during Tuesday's regular session. The company's market cap stands at $139.9 million. </li>
<li>Sonim Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) shares decreased by 48.07% to $0.63. The company's market cap stands at $12.6 million. </li>
<li>Aeva Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NASDAQ">AEVA</a>) stock decreased by 24.01% to $28.72. The market value of their outstanding shares is at $2.0 billion. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock declined by 16.93% to $0.13. The company's market cap stands at $17.0 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock decreased by 15.15% to $4.79. The company's market cap stands at $3.5 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock fell 14.35% to $2.54. The market value of their outstanding shares is at $1.3 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEVA

ARBK

AUUD

BMNR

CLRO

SAIH

SLNHP

SONM

SVRE

WOLF

YAAS

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Roth Capital analyst Joe Reagor downgrades Hecla Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) from Buy to Neutral and maintains the price target from $6 to $6.

Comments

GOLDEN RAPTURE MNG CORP by GOLDEN RAPTURE MNG CORP.

GOLDEN RAPTURE MNG CORP by GOLDEN RAPTURE MNG CORP. (GLDRF) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO